News · 7 March 2026

Study says weight-loss jab can be $3 monthly

Access to a crucial weight-loss drug could vastly improve for millions globally, as new research suggests a substantial cost reduction. The injectable form of semaglutide, an essential medicine designated by the World Health Organization, might be produced for just $3 each month. This finding comes from a pre-print analysis, revealing patents are expiring in several countries from March 21.

By BriefTea Editorial · 7 March 2026 at 19:09

Reported by Guardian · How we write briefs

Get the app

More briefs

WorldTurkey, Saudi Arabia and Pakistan to discuss new mutual protection deal on Monday WorldIran's unseen supreme leader urges Gulf countries to fight a shared enemy BusinessIceland supermarket boss tells the Chancellor to cut business taxes for employers GeneralNigel Farage's £5m donor has major stakes in arms industry PoliticsTreasury officials advise John Healey to tax banks and oil companies more HealthCorrecting hearing loss can cut dementia risk by almost half Browse all stories →